Back to Project
ePA Solution Demo
| ID | Patient Name | Drug/Service | Provider | Created Date | Status |
|---|---|---|---|---|---|
| EPA-2025-001 | John Smith | Humira (adalimumab) | City Medical Group | Jan 2, 2025 | New |
| EPA-2025-003 | Robert Johnson | Eliquis (apixaban) | Heart & Vascular Institute | Jan 1, 2025 | Question Respond |
| EPA-2025-004 | Susan Williams | Dupixent (dupilumab) | Dermatology Associates | Dec 28, 2024 | New |
| EPA-2025-007 | Michael Thompson | Jardiance (empagliflozin) | Endocrine Specialists | Jan 3, 2025 | New |
| EPA-2025-009 | James Wilson | Entresto (sacubitril/valsartan) | Cardiology Partners | Jan 1, 2025 | Question Respond |
| EPA-2025-011 | Thomas Moore | Repatha (evolocumab) | Lipid Clinic | Jan 2, 2025 | New |